Does QTI pay a dividend and is it safe?

QT Imaging Holdings Inc. (QTI) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Stock Ratings / Health Care / QTI / dividends

POCI (31) ITOC (33) ECOR (29) OM (34) ⌘ Pro Terminal →

QT Imaging Holdings Inc. (QTI) Dividend Safety Gauge & 10-Year DRIP Compounder

Q: Where is QTI trading relative to its 50-day, 200-day, and 52-week technical levels?

QTI last traded at $2.15 (+0.47% on volume of 15,384 shares), positioning the stock -16.02% below its 50-day simple moving average ($2.56) and -51.58% below its 200-day simple moving average ($4.44). Across its 52-week range of $2.14 to $7.60, QTI sits at the 0.2% percentile with a 14-day RSI of 33.6 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.88 to $2.42).

$2.15 +0.47% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.15

QT Imaging Holdings Inc. (QTI) carries a Roarable Rating of E (Strong Sell) with 29/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $31.3M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on QTI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is QTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, QT Imaging Holdings Inc. (NASDAQ: QTI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 29/100 at a spot price of $2.15 (+0.47% 1D, market cap $31.3M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 8/20, FRED Macro Regime Fit 8/20, and Executive Insider Alignment 5/20. Across 1015 tracked Health Care issuers, QTI ranks #843 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does QTI compare to POCI and ITOC in the Health Care sector?

▼

Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), QTI carries a Roarable E (29/100 RQD), trailing P/E of N/A, gross margin of 45.4%, and ROIC of -35.0%. By comparison, POCI (Precision Optics Corporation Inc.) holds a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $51.1M) and ITOC (iTonic Holdings Ltd (Class A)) posts a E grade (33/100 RQD, P/E N/A, ROIC -35.0%, cap $19.0M). Among the 5-stock peer group, QTI leads on earnings multiple (N/A) while OM leads on capital efficiency (-28.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for QTI?

▼

Per QTI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001844505), QT Imaging Holdings Inc. generated $18.9M in revenue (+287.9% YoY), -$21.1M in net income, and -$9.1M in free cash flow against $23.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.15 (-0.11%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 5/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (29/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.8% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 Quant Analysts Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw E · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-13% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for QTI)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (29/100 Composite)

🔍 WHY QTI SCORES 29/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (28% of score)

Altman Z-Score 0.20 (DISTRESS RISK (<1.8)) • Piotroski F-Score 4/9

▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (28% of score)

FRED Regime × Technicals: 2% of 52W Range • RSI-14 at 33.6 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$2.45-4.9% Next Q

Q2 (-2Q)

Grade E$2.33-2.1% Next Q

Q3 (-1Q)

Grade E$2.28-5.7% Next Q

Current

Grade E$2.15-9.8% Hist 90D α

Trajectory: E (37) → E (29)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a QTI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While QTI currently carries a cautious 29/100 (E) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.56) and Max Pain ($2.26) forces dealer call-delta covering toward $7.98.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $QTI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “QTI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 29%NO 71%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (16.3% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $45,269

Est. Year-10 Shareholder Yield: $815/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$11.6K

Yr 1

$13.5K

Yr 2

$15.7K

Yr 3

$18.3K

Yr 4

$21.3K

Yr 5

$24.7K

Yr 6

$28.8K

Yr 7

$33.5K

Yr 8

$38.9K

Yr 9

$45.3K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring QTI)

✓Walkthrough of QTI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

QTI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -67.08%🛡️ HOLDING TREND SUPPORT

2026-11-03O $2.21H $2.21L $2.14C $2.15VOL 22.7K

RES: $2.83SUP: $2.12SMA50: $2.56SMA200: $4.44

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

QTI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 QTI Butterfly Map → + Track QTI →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

8.0%/yr Implied 5Y Growth

vs. +287.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on QTI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for QTI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for QTI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (QTI)

Health Care Rank #843 of 1015 ⚔️ POCI vs QTI Full Matrix →

1. Head-to-Head Health Care Peer Comparison (QTI vs. POCI, ITOC, ECOR, OM)

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, QT Imaging Holdings Inc. (QTI) ranks #843 by composite RQD confidence (29/100, grade E) and #791 by equity capitalization ($31.3M). Within this direct 5-issuer industry benchmark cohort, QTI leads on earnings valuation at N/A trailing P/E, while OM leads on capital efficiency and profitability with -28.0% ROIC and 39.1% gross margin. OM currently holds the highest overall quantitative score in the immediate peer group at 34/100 (E) compared with QTI at 29/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
QTI ACTIVE QT Imaging Holdings Inc.	E	29/100	—	45.4%	-35.0%	+0.47%	$31.3M	Benchmark Subject
POCI Precision Optics Corporation Inc.	E	31/100	—	17.8%	-35.0%	+3.23%	$51.1M	/poci-vs-qti →
ITOC iTonic Holdings Ltd (Class A)	E	33/100	—	62.6%	-35.0%	-9.61%	$19.0M	/itoc-vs-qti →
ECOR electroCore Inc.	E	29/100	—	86.8%	-35.0%	-4.79%	$67.8M	/ecor-vs-qti →
OM Outset Medical Inc.	E	34/100	—	39.1%	-28.0%	-0.25%	$75.8M	/om-vs-qti →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001844505 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), QT Imaging Holdings Inc. (QTI) reported GAAP revenue of $18.9M (+287.9% vs. FY2024 revenue of $4.9M , and +46796.3% cumulative change since FY2023) , GAAP net income of -$21.1M, operating cash flow of -$9.0M, and free cash flow of -$9.1M (+10.3% YoY). On the balance sheet, QTI closed FY2025 with $23.0M in total assets against $0 in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$18.9M	-$21.1M	-$9.0M	-$9.1M	$23.0M	—
FY2024 (FY)	2024-12-31	$4.9M	-$9.0M	-$10.0M	-$10.1M	$6.1M	—
FY2023 (FY)	2023-12-31	$40.4K	-$6.1M	-$2.7M	-$2.7M	—	—

3. QTI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is QTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does QTI compare to POCI and ITOC in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for QTI?

Where is QTI trading relative to its 50-day, 200-day, and 52-week technical levels?

QTI last traded at $2.15 (+0.47% on volume of 15,384 shares), positioning the stock -16.02% below its 50-day simple moving average ($2.56) and -51.58% below its 200-day simple moving average ($4.44). Across its 52-week range of $2.14 to $7.60, QTI sits at the 0.2% percentile with a 14-day RSI of 33.6 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.88 to $2.42).

Direct Sub-Reports: QTI RQD Cockpit QTI 12M Forecast QTI Earnings & Move QTI Dividends & DRIP QTI Insiders & 13F QTI Whale Options QTI Profit Sankey QTI News & Why

ROARABLE RATING BRIEF • RQD 29/100 (E) ✓ SEC XBRL & RQD VERIFIED

QTI — QT Imaging Holdings Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

QT Imaging Holdings Inc. (QTI) earns a live Roarable RQD composite score of 29/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $2.15 (+0.47% 1D, market capitalization $31.3M).

Fundamental Cash Engine (5/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 45.4%, operating margin of -23.4%, and free cash flow yield of —.
Whale 13F & Options Flow (3/20) + Insider Conviction (5/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (8/20) + Forensic Balance Sheet (8/20): Incorporates a 1.00x equity beta, Altman Z-Score of 0.20, Piotroski F-Score of 4/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

. Is a NASDAQ-listed issuer in the Health Care sector, within the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry. Per the recent news, the company's Breast Acoustic CT™ Scanner is available through a national group purchasing agreement with Premier.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), QT Imaging Holdings Inc. (QTI) reported $18.9M in annual revenue (up from $4.9M in FY2024, +287.9% YoY) and -$21.1M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($40.4K revenue, -$6.1M net income) through FY2025, QTI scaled operating cash flow to -$9.0M and free cash flow to -$9.1M, backed by $23.0M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (E • RQD 29/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 3/20. With Fundamental Cash Engine at 5/20 and Institutional Whale Flow at 3/20, sustained execution supports upside toward the upper end of the $2.14 – $7.60 52-week range.
🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -23.4% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

The prospective investor should monitor the upcoming Q3 results and any commercial-channel developments, such as adoption through the Premier group purchasing arrangement, as the source-supported ripple points.

Key Question #1: Can QTI sustain or expand its -23.4% operating margin and -35.0% ROIC against Biotechnology: Electromedical & Electrotherapeutic Apparatus peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $18.9M and free cash flow of -$9.1M, how will capital allocation balance growth reinvestment against $0 in total debt?
Key Question #3: How sensitive is QTI's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

QTI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for QT Imaging Holdings Inc. (QTI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to QTI Debate Forum (3) ↓

🟢 CATALYST Yahoo Finance • 1d ago

QT Imaging Holdings (QTI) Stock Fair Value Falls As Growth Outlook Turns More Cautious

Yahoo Finance report covering QT Imaging Holdings Inc. (QTI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 1d ago

QT Imaging Holdings, Inc. Estimates – NASDAQ:QTI

TradingView report covering QT Imaging Holdings Inc. (QTI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Stock Titan • 1d ago

Third-quarter results are due after close Nov. 10; QT Imaging's call will stream live at 4:30 p.m. Eastern.

Stock Titan report covering QT Imaging Holdings Inc. (QTI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Moomoo • 1d ago

D. Boral Capital Initiates QT Imaging(QTI.US) With Buy Rating, Announces Target Price $9

Moomoo report covering QT Imaging Holdings Inc. (QTI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Business Wire • 1d ago

QT Imaging’s Breast Acoustic CT™ Scanner Now Available Through National Group Purchasing Agreement with Premier

Business Wire report covering QT Imaging Holdings Inc. (QTI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo! Finance Canada • 1d ago

QT Imaging Holdings, Inc. (QTI) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance Canada report covering QT Imaging Holdings Inc. (QTI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Traders Union • 2d ago

Live QT Imaging Holdings, Inc. (QTI) Technical Analysis

Traders Union report covering QT Imaging Holdings Inc. (QTI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Benzinga • 11d ago

D. Boral Capital Initiates Coverage On QT Imaging Holdings with Buy Rating, Announces Price Target of $9

D. Boral Capital analyst Patrick McCann initiates coverage on QT Imaging Holdings (NASDAQ:QTI) with a Buy rating and announces Price Target of $9.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

QTI Bull vs. Bear Conversation Board — What's Your Call at $2.15?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON QTI 🐻 33% BEARISH CONVICTION

BR BreakoutHunter RQD DEBATE OPENER • Swing & Catalyst Trader 🐂 BULLISH 🎯 Target: $2.61 (+22.0%)

📌 Pinned Debate

Revenue rose from $4.9M in FY 2024 to $18.9M in FY 2025 and an analyst initiated coverage with a Buy rating and $9 target.

Picked up a starter position in QTI in my $100K Virtual Cash book at $2.14. Revenue rose from $4.9M in FY 2024 to $18.9M in FY 2025 and an analyst initiated coverage with a Buy rating and $9 target.. Trading inside a $2.14–$7.60 52-week range with 0.0% FCF yield gives solid downside support if Biotechnology: Electromedical & Electrotherapeutic Apparatus multiples expand this quarter.

ArenaChamp_24 🐂 BULL

@ForensicBear Fair point on current EV/EBITDA multiples, but you're ignoring the forward operating leverage in Biotechnology: Electromedical & Electrotherapeutic Apparatus. If gross margin (45.4%) holds, EPS grows into the multiple faster than bears think.

FO ForensicBear RQD DEBATE OPENER • 10-K Footnote Auditor 🐻 BEARISH 🎯 Target: $1.82 (-15.0%)

Spot @ $2.14

Negative ROIC of -35%, a 0% FCF yield, and an Altman Z-Score of 0.2 signal weak cash generation and elevated financial-distress risk.

Negative ROIC of -35%, a 0% FCF yield, and an Altman Z-Score of 0.2 signal weak cash generation and elevated financial-distress risk.. Look at the math on QTI: paying current EV/EBITDA multiples for -35.0% ROIC and -23.4% operating margins leaves zero margin of safety if Biotechnology: Electromedical & Electrotherapeutic Apparatus demand softens. I'd wait for a retest of $1.88 before getting long.